Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 301–400 of 749
Long Noncoding RNAs and Mitochondrial Homeostasis in the Development of Diabetic Retinopathy
Kowluru, R. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.915031 · Cited by 19
“In addition, many inflammatory markers including cytokines and leukostasis, are also elevated in diabetic retinopathy (59), and retinal glial cells, the cells that are between vasculature and neurons of the retina, also initiate the inflammatory cascade (60).”
BackgroundThe Role of Adaptive Immunity in Diabetic Retinopathy
Xue, M., Mao, X., Chen, M., Yin, W., Yuan, S., & Liu, Q. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216499 · Cited by 19
Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
Ferrara, M., Loda, A., Coco, G., Grassi, P., Cestaro, S., Rezzola, S., Romano, V., & Semeraro, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030912 · Cited by 20
Zhou, Y., Yue, S., Li, L., Zhang, J., Chen, L., & Chen, J. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111064 · Cited by 15
Liang, H., Ren, Y., Huang, Y., Xie, X., & Zhang, M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118078 · Cited by 15
Adán, A., López, F. A. C., Figueroa, M. S., Cervera, E., Ascaso, F. J., Udaondo, P., Abraldes, M. J., Reyes, M., Pazos, M., Pessoa, B., et al. (2020) · Clinical ophthalmology · doi:10.2147/opth.s252359 · Cited by 15
Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
Ravi, S., Punabaka, J., Shanmugam, B., Ganjikunta, V. S., Shanmugam, K. R., & Kesireddy, S. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200730221035 · Cited by 16
Haq, Z., Yang, D., Psaras, C., & Stewart, J. M. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.3.12 · Cited by 15
Protective Role of microRNA-200a in Diabetic Retinopathy Through Downregulation of PDLIM1
Wan, W., Long, Y., Jin, X., Li, Q., Wan, W., Liu, H., & Zhu, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s303540 · Cited by 15
Gholami, M., Coleman‐Fuller, N., Salehirad, M., Darbeheshti, S., & Motaghinejad, M. (2024) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_5_23 · Cited by 16
“…(PG), Janus kinase/signal transducers and activators of transcription (JAK/STAT) and toll‑like receptor (TLR) cascade and GF. [16,115,119,120] COX‑PG signaling cascades are activated in DM subjects, leading to neuropathy, retinopathy, and other comorbidities of neurodegenerative…”
BackgroundCiorba, A. L., Saber, S., Abdelhamid, A. M., Keshk, N., Elnaghy, F., Elmorsy, E. A., Abu‐Khudir, R., Hamad, R. S., Abdel‐Reheim, M. A., Farrag, A. A. M., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107307 · Cited by 25
Ocular Delivery of Polyphenols: Meeting the Unmet Needs
Krstić, L., González-García, M. J., & Diebold, Y. (2021) · Molecules · doi:10.3390/molecules26020370 · Cited by 15
Eshaq, R. S., & Harris, N. R. (2021) · Microcirculation · doi:10.1111/micc.12717 · Cited by 16
Wang, M., Sheng, K.-J., Fang, J.-C., Zhao, H., Lu, S., Liu, Z., & Chen, B.-T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114829 · Cited by 14
Klotho: A new therapeutic target in diabetic retinopathy?
Puddu, A., & Maggi, D. C. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.1027 · Cited by 14
Choroidal Mast Cells and Pathophysiology of Age-Related Macular Degeneration
Malih, S., Song, Y., Sorenson, C. M., & Sheibani, N. (2023) · Cells · doi:10.3390/cells13010050 · Cited by 14
Rübsam, A., Hössl, L., Rau, S., Böker, A., Zeitz, O., & Joussen, A. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061819 · Cited by 14
“Since DME is an inflammatory disease, there has been a concern that IOI may be more common in DME than in controls [26,27].”
BackgroundSelf-citationChen, Y., Yu, Y., & An, J. (2024) · Nutrients · doi:10.3390/nu16091393 · Cited by 19
“Elevated concentrations of pro-inflammatory cytokines and chemokines, encompassing various inflammatory mediators, have been detected in ocular samples from DR patients [80], and upregulated pro-inflammatory cytokines may directly or indirectly induce angiogenesis [81,82].”
BackgroundNwokoye, P. N., & Abilez, O. J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1336910 · Cited by 21
Si, Y., Chen, Q., Xiong, X., & Zheng, M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01419-4 · Cited by 16
“Chemokines play a crucial role in recruiting and activating monocytes and leukocytes in DR, and their production contributes to the elevation of MLR [35, 36].”
BackgroundPadovani-Claudio, D. A., Morales, M. S., Smith, T. E., Ontko, C. D., Namburu, N. S., Palmer, S. A., Jhala, M. G., Ramos, C. J., Capozzi, M. E., McCollum, G. W., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111454 · Cited by 19
“Some of the top transcripts upregulated by both IL-1 β and TNF α in hMC have been previously associated with tissue inflammation and/or retinopathy (i.e., CCL20, IL1B, CXCL8, CXCL3, and VCAM) [9,38,54,55,86,87,94,95].”
Yang, F., Tang, M., Xiang, X., Liu, K., & Xu, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6970 · Cited by 15
Liu, Y., Duan, C., Fang, D., Liu, Y., Xu, H., Zheng, Y., Xuan, Y., Wang, L., Ye, L., Su, R., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.014 · Cited by 14
Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
Liu, X., Xu, B. Y., & Gao, S.-H. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.4.20 · Cited by 15
The impact of zinc on the molecular signaling pathways in the diabetes disease
Asghari, K., Shargh, Z., Fatehfar, S., Chodari, L., & Sameei, P. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.126985 · Cited by 14
Weigelt, C. M., Zippel, N., Fuchs, H., Rimpelä, A., Schönberger, T., Stierstorfer, B., Bakker, R. A., & Redemann, N. H. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.5.18 · Cited by 17
Hameed, S. S., Swain, S., Jana, S., Chhablani, J. K., Ali, M. J., Pappuru, R. R., Tyagi, M., Vishwakarma, S., Sailaja, N., Chakrabarti, S., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01445 · Cited by 15
Kattar, A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1953466 · Cited by 16
“Diabetic retinopathy involves damage to the retinal blood vessels, which has disastrous effects on the retina [34].”
BackgroundEvidence for a dysfunction and disease-promoting role of the circadian clock in the diabetic retina
Vancura, P., Oebel, L., Spohn, S. K. B., Frederiksen, U., Schäfer, K., Sticht, C., & Spessert, R. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108751 · Cited by 16
Koh, E. S., Han, K., Kim, M. K., Kim, E. S., Lee, M.-K., Nam, G. E., & Kwon, H.-S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.121 · Cited by 13
“Mounting evidence has demonstrated that the diabetic milieu leads to increased local expression of inflammatory molecules, such as cytokines, chemokines and growth factors, and involves various expression changes in several inflammatory mediators in the development of DN and DR [2,4-6].”
BackgroundShi, R., Lu, Y., Liu, D., & Guo, Z. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01775-x · Cited by 13
“Increasing evidence points to serum LDL and TC as key players in diabetes-associated retinal neurovascular structural impairment due to inflammation [15, 17, 18].”
BackgroundRetinal vascular geometry detection as a biomarker in diabetes mellitus
Li, M., Wang, G., Xia, H., Feng, Z., Xiao, P., & Yuan, J. (2021) · European Journal of Ophthalmology · doi:10.1177/11206721211033488 · Cited by 13
“fundus fluorescein angiography and optical coherence tomography if necessary, (3) a refractive media opacity that prevented the fundus from being detected clearly, (4) a dioptric power greater than ±3 D, and (5) the inability to cooperate with the examinations.”
BackgroundXing, B., Xu, X., Li, C., Zhao, Y., Wang, Y., & Zhao, W. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02824-w · Cited by 15
“A pile of evidence has revealed that inflammation and oxidative stress contributed vital parts in the pathophysiology of DR [20, 21].”
BackgroundWang, J.-J., Chen, Z.-L., Wang, D., Wu, K., Huang, W., & Zhang, L. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.016 · Cited by 13
Systemic Lipopolysaccharide Exposure Exacerbates Choroidal Neovascularization in Mice
Tsioti, I., Steiner, B. L., Escher, P., Zinkernagel, M. S., Benz, P. M., & Kokona, D. (2022) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2022.2147547 · Cited by 14
“…shifting of microglia to a pro-inflammatory phenotype and large influx of pro-inflammatory macrophages from the periphery into the retina (Figures 2, 3) correlates with exacerbation of fluorescein leakage (Figure 1) and increase of Vegfα mRNA expression by Glul - expressing cells adjacent to the…”
BackgroundLi, B., Li, W., Guo, C., Guo, C., & Chen, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02086-z · Cited by 15
“Activation, value-added, edema, and hypertrophy of glial cells in the retinal NVU may be the main causes of INL thickening [28].”
BackgroundDiabetes, Diabetic Retinopathy, and Inflammatory Disorders
Sheemar, A., Goel, P., Thakur, P. S., Takkar, B., Kaur, I., Rani, P. K., Tyagi, M., Basu, S., & Venkatesh, P. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2023.2203742 · Cited by 16
“…elevated cytokine release in DM patients having high HbA 1C levels has been demonstrated by Hoffman et al. 25 The ligands for Toll-like receptors 2 and 4 (TLR2 and TLR4) regulating inflammation were also found to be higher in T1DM individuals as compared to controls suggesting active…”
Soe, H. M. S. H., Maw, P. D., Asasutjarit, R., Loftsson, Þ., & Jansook, P. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104936 · Cited by 13
Glass, J., Robinson, R. L., Greenway, G., Jones, G., & Sharma, S. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.15.1 · Cited by 13
“27–29 MGCs interact with endothelial cells (ECs), which we have shown do not express mIL-6R, 16 to regulate the tightness of the blood retinal barrier (BRB) 6,29–34 and retinal angiogenesis.”
Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation
Rapp, J., Hospach, A., Liang, P., Schwämmle, M. E., Renz, L. M., Agostini, H. T., Schlunck, G., & Bucher, F. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.22 · Cited by 14
A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25
Hu, Q., Zhang, X., Peng, H., Guan, J., Huang, Z., Jiang, B., & Sun, D. (2024) · Inflammation · doi:10.1007/s10753-024-01991-x · Cited by 13
“Neuroinflammation is a typical feature of DR [23].”
BackgroundTatsumi, T., Kaiho, T., Iwase, T., Miura, G., Shimizu, D., Niizawa, T., Ozawa, Y., Arai, M., Oshitari, T., Takatsuna, Y., et al. (2024) · Medicina · doi:10.3390/medicina60050732 · Cited by 13
“Moreover, inflammatory factors like tumor necrosis factor-α (TNF-α ), IL-1 α , IL-1 β , IL-8, IL-10, and placental growth factor (PlGF) have been identified as contributors to the inflammatory processes underlying the development of DME [8].”
BackgroundFXR suppress Müller cell activation by regulating cGAS / STING pathway in diabetic retinopathy
Wang, Z., Zhang, X., Tan, C., Zhuang, M., Zhu, L., Zheng, X., Yao, Y., & Wei, T. (2025) · FEBS Journal · doi:10.1111/febs.17421 · Cited by 15
Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases
Chen, C., Wang, C., Zhou, X., Xu, L., Chen, H., Qian, K., Jia, B., Su, G., & Fu, J. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106578 · Cited by 17
Sanchez, M. C., & Chiabrando, G. A. (2022) · ASN NEURO · doi:10.1177/17590914221136365 · Cited by 14
“In proliferative retinopathies, MGCs also release vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) involved in the formation of retinal neovascularization and extracellular matrix remodeling during proliferative stages (Coughlin et al., 2017; Lorenc et al., 2015; Lorenc et al., 2017).”
BackgroundInfluentialTomić, M., Vrabec, R., Pauk, S. V., Bulum, T., & Ljubić, S. (2020) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2020.1789921 · Cited by 16
Deletion of toll-like receptor 4 ameliorates diabetic retinopathy in mice
Fu, H., & Liu, H. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1841795 · Cited by 13
“Deletion of TLR4 in mice attenuated inflammatory responses in the retina of diabetic mice Numerous studies proved that inflammation played a crucial role in the development of diabetic retinopathy (Rubsam et al. 2018).”
BackgroundCanovai, A., Amato, R., Melecchi, A., Monte, M. D., Rusciano, D., Bagnoli, P., & Cammalleri, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.811818 · Cited by 13
“The activation of inflammatory processes triggers glial reactivity, which participates to the chronic inflammatory response (Rübsam et al., 2018).”
BackgroundMathala, N., Akula, A., Hegde, S., Bitra, V. R., & Sachedev, V. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190823155534 · Cited by 12
Zou, W., Lu, Q., Xue, Z., Pan, Y., Xu, Q., & Wang, K. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666221017120334 · Cited by 12
Chen, H., Zhang, X., Liao, N., Ji, Y., Mi, L., Gan, Y., Su, Y., & Wen, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020252 · Cited by 13
“Currently, immunity dysregulation is considered as a significant pathogenic mechanism in DR, both locally as well as systematically (5).”
BackgroundBatsos, G., Christodoulou, E., Christou, E. E., Galanis, P., Katsanos, A., Limberis, L., & Stefaniotou, M. I. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02733-z · Cited by 12
“3 LCN2 levels of the controls, DME and PDR patients targets in cases that are refractory to anti-VEGF treatment.”
BackgroundInfluentialWan, L., Chen, W., & Wu, G. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2023.06.04 · Cited by 13
Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy—A Review
Błaszkiewicz, M., Walulik, A., Florek, K., Górecki, I., Sławatyniec, O., & Gomułka, K. (2023) · Biomedicines · doi:10.3390/biomedicines11112951 · Cited by 20
Association Between Triglyceride-Glucose Index and Diabetic Retinopathy: A Meta-Analysis
Yu, L., & Li, B. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2279-7112 · Cited by 14
“Multiple investigations conducted on both diabetic patients and animal models have demonstrated that the diabetic environment induces heightened local production of inflammatory molecules, including cytokines, chemokines, and growth factors [43].”
BackgroundYe, X., Liu, Y., Chen, C., Sun, Y., Li, F., Fu, Y., Luo, J., Su, L., & Chi, W. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102209 · Cited by 15
Biomarkers for diabetic retinopathy
Budzinskaya, M. V., Липатов, Д. В., Pavlov, V., & Petrachkov, D. V. (2019) · Diabetes Mellitus · doi:10.14341/dm10045 · Cited by 15
Al‐Taie, A., Elseidy, A. S., Arueyingho, O., Hafeez, A., & Ahmad, S. (2021) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_153_21 · Cited by 13
Liu, L., Li, X., Cai, W., Guo, K., Shi, X., Tan, L., Yao, Z., Jing, X.-S., Wang, W., Zhou, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014991 · Cited by 14
“Chronic inflammation is extensively involved in the development of DR, the process of which is accompanied by elevated levels of a range of proinflammatory factors, including TNF-α, IL-1β, and MCP1(Rubsam et al., 2018).”
BackgroundIdentification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells
Mijit, M., Liu, S., Sishtla, K. L., Hartman, G. D., Wan, J., Corson, T. W., & Kelley, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021101 · Cited by 11
“In the vitreous of patients affected with retinopathies, increased levels of pro-inflammatory molecules, including TNF-α, IL-6, IL-8, and others, have been observed [7,8].”
BackgroundVos, S., Aaron, R., Weng, M., Daw, J., Rodriguez-Rivera, E., & Subauste, C. S. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.7.17 · Cited by 12
Development and characterization of an in vitro system of the human retina using cultured cell lines
Churm, R., Dunseath, G. J., Prior, S. L., Thomas, R., Banerjee, S., & Owens, D. R. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13578 · Cited by 12
“We hypothesise that the triple-culture system promotes the functionality of the BRB, not only structurally through the promotion of TJP1/ZO1, but also by an increase in the expression of beneficial growth factors such as PEDF and decreasing the expression of detrimental growth factors such as VEGF.”
BackgroundInfluentialEshaq, R. S., & Harris, N. R. (2019) · Microcirculation · doi:10.1111/micc.12596 · Cited by 14
Yu, M., Zhang, L., Sun, S., & Zhang, Z. (2021) · BMC Ophthalmology · doi:10.1186/s12886-021-02215-8 · Cited by 12
Therapeutic Implications of Curcumin in the Treatment of Inflammatory Eye Diseases: A Review
Thiruvengadam, M., Heydari, M., Khalili, M. R., Nowroozzadeh, M. H., Bamdad, S., Sahebkar, A., & Shariati, M. A. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220609085614 · Cited by 12
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Lee, S. H. S., Lee, J. Y., Choi, J., Kim, H. J., Kim, J., Cha, S., Lee, K. J., Woo, H., Park, K., & Lee, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269951 · Cited by 14
“Müller cells are especially involved in DR-associated inflammatory processes, as hyperglycemia induces Müller cells to express a number of pro-inflammatory cytokines [4], including IL-1β and TNF-α, which together upregulate IL-8 [30].”
BackgroundNouralishahi, A., Fazlinejad, N., Pecho, R. D. C., Zaidan, H. K., Kheradjoo, H., Amin, A. H., & Mohammadzadehsaliani, S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154619 · Cited by 12
Saucedo, L., Pfister, I. B., Schild, C., & Garweg, J. G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293139 · Cited by 11
The relationship between blood vitamin A levels and diabetic retinopathy: a population-based study
Choi, Y.-J., Kwon, J. W., & Jee, D. (2024) · Scientific Reports · doi:10.1038/s41598-023-49937-x · Cited by 12
Fan, Z., Hu, Y., Chen, L., Lu, X., Zheng, L., Ma, D., Li, Z., Zhong, J., Lin, L., Zhang, S., et al. (2024) · Eye · doi:10.1038/s41433-024-02938-0 · Cited by 11
Li, Z., Hu, F., Xiong, L., Zhou, X., Dong, C., & Zheng, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118641 · Cited by 12
Zhou, L., Sun, H., Chen, G., Li, C., Liu, D., Wang, X., Meng, T., Jiang, Z., Yang, S., & Yang, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05654-1 · Cited by 12
“Furthermore, other signaling pathways, particularly those associated with inflammatory responses such as TNF-α, complement factor, prostanoids etc., have also been implicated as contributory mechanisms [7–9].”
BackgroundLong, P., Guo, C., Wen, T., Luo, T., Yang, L., Li, Y., 文爱东, Wang, W., Wen, X., & Long, P. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118963 · Cited by 14
Jafarzadeh, F., Javanbakht, A., bakhtar, N., Dalvand, A., Shabani, M., & Mehrabinejad, M.-M. (2021) · International Ophthalmology · doi:10.1007/s10792-021-02011-9 · Cited by 11
Tasquinimod efficacy and S100A9 expression in glucose-treated HREC cells
Jin, J., Zhang, J., & Bu, S. (2021) · International Ophthalmology · doi:10.1007/s10792-021-02038-y · Cited by 13
“Increasing evidence indicates that inflammation is a critical factor in the development of DR [8, 9].”
BackgroundAlsabaani, N. A., Osman, O. M., Dallak, M. A., Morsy, M. D., & Al-Dhibi, H. A. (2022) · Journal of Ophthalmology · doi:10.1155/2022/3044202 · Cited by 14
Pathophysiology and diagnosis of diabetic retinopathy: a narrative review
Estaji, M., Hosseini, B., Qomi, S. B., & Ebrahimi, B. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221145040 · Cited by 17
“transcription of proinflammatory cytokines, acute phase proteins, and chemokines, such as IL-6, TNF-a, IL-1b, and monocyte chemoattractant protein-1 (MCP-1).(32) In both kinds of diabetic models, animal or human, in different phases of DR, chronic low-grade inflammation extensively has been recognized.”
BackgroundCioanca, A. V., Wooff, Y., Aggio‐Bruce, R., Sekar, R., Dietrich, C. A., & Natoli, R. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12393 · Cited by 12
“…rapid cytoskeletal changes, the release of inflammatory cytokines and chemokines, and a loss of homeostatic functioning, culminating in neuronal cell death (Eastlake et al., 2016; Kauppinen et al., 2012; Kumar et al., 2013; Olivares-González et al., 2021; Rübsam et al., 2018; Rutar et al., 2015).”
BackgroundMbaoji, F. N., Onwuka, A. M., Onu, S., Peter, I. E., Nweze, J. A., & Okonta, L. E. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1738163 · Cited by 11
“It is triggered by the immune system cells and characterized by dysfunction of the tissues and organs, leading to swelling, heat, redness, and pain [1].”
BackgroundCellular targets in diabetic retinopathy therapy
Rodríguez, M. L., Millán, I., & Ortega, Á. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i9.1442 · Cited by 13
Sinclair, S. H., & Schwartz, S. S. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paendo.1.2020.4 · Cited by 12
Li, X., & Xie, X. (2022) · Journal of Ophthalmology · doi:10.1155/2022/4007002 · Cited by 11
“An increasing number of studies have shown [19, 20] that inflammation is strongly associated with early neuromicrovascular pathological changes in DR, that oxidative stress, formation of late glycosylation end products, and 0.”
BackgroundNanoliposome-based drug delivery systems for the treatment of diabetes mellitus: a review
Umar, M., Sherazi, T. A., Talha, M., Ramadan, M. F., Ahmed, A. E., Taha, R., & Naqvi, S. A. R. (2025) · RSC Advances · doi:10.1039/d5ra07152f · Cited by 11
Lepre, C. C., Russo, M., Trotta, M. C., Petrillo, F., D’Agostino, F. A., Gaudino, G., D’Amico, G., Campitiello, M. R., Crisci, E., Nicoletti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119721 · Cited by 10
“In particular, in the human retina, P2X7R is localized in INL, OPL and GCL and is expressed by human retinal Müller cells, the native retinal pigment epithelium (RPE) and adult retinal pigment epithelial cell line-19 (ARPE-19) [160].”
BackgroundShu, Y., Zhang, C., Bi, Y., & Zhang, J. (2025) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2025.100168 · Cited by 12
Ergin, E., Dascălu, A. M., Stana, D., Tribus, L. C., Arsene, A. L., Nedea, M. I., Şerban, D., Nistor, C., Tudor, C., Dumitrescu, D., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13061308 · Cited by 10
“Several studies proved that NLR, PLR, and SII are higher in diabetic patients, compared to healthy controls [43–45].”
Vajdi, M., Mahmoudinezhad, M., & Farhangi, M. A. (2021) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000702 · Cited by 9
Zeng, X., Deng, Y. J., Yuan, M., He, Q., Wu, Y., & Li, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9990937 · Cited by 10
Wang, F., Kang, E. Y., Liu, C.-H., Ng, C. Y., Shao, S., Lai, E. C., Wu, W., Huang, Y., Chen, K., Lai, C., et al. (2022) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000571 · Cited by 10
Hisamuddin, A. S.-D. B., Naomi, R., Manan, K. A. B., Bahari, H., Othman, F., Embong, H., Ismail, A., Ahmed, Q. U., Jumidil, S. H., Hussain, M. K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1175907 · Cited by 12
“In the proliferative phase, fragile aberrant vessels start to form, whereas a clear vascular lesion is visibly designated as vascular tortuosity, microaneurysms, or retinal hemorrhages in the non-proliferative phase (Rübsam et al., 2018).”
BackgroundMohammad, H. M. F., Eladl, M. A., Abdelmaogood, A. K. K., Elshaer, R. E., Ghanam, W., Elaskary, A. A., Saleh, M. A. K., Eltrawy, A. H., Ali, S. K., Moursi, S. M. M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123202 · Cited by 10
Nuclear proteins and diabetic retinopathy: a review
Li, B., Hussain, W., Jiang, Z.-L., Wang, J., Hussain, S., Yasoob, T. B., Zhai, Y., Ji, X., & Dang, Y. (2024) · BioMedical Engineering OnLine · doi:10.1186/s12938-024-01258-4 · Cited by 11
“Microglia, the resident immune cells of the retina, play an important role in the inflammatory response associated with diabetic retinopathy [62].”
BackgroundPang, C., Cen, L., Ng, T. K., & Chu, W. K. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336135 · Cited by 10
“In experimental diabetic retinopathy, there are retinal perturbations and inflammation, leading to consequential neuro-glial disruptions that are difficult to treat (Rübsam et al., 2018).”
Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
Yener, N. P., Özgen, G., Balıkçı, A. T., Özgen, L., & Aydın, G. A. (2021) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2021.09.1057 · Cited by 9
Chen, Y., Dong, J., Liu, W., Xia, Q., Liu, T., Liu, S., Song, Z., & Li, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135547 · Cited by 9
Autophagy-dependent ferroptosis may play a critical role in early stages of diabetic retinopathy
Sun, W., An, X., Zhang, Y., Tang, S., Sun, Y., Kang, X., Jiang, L., Zhao, X., Gao, Q., Ji, H., et al. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i11.2189 · Cited by 10
Heiden, R., Hannig, L., Bernhard, J. S., Vallon, M., Schlecht, A., Hofmann, N., Ergün, S., Hoschek, F., Wagner, M., Neueder, A., et al. (2025) · iScience · doi:10.1016/j.isci.2024.111740 · Cited by 12
Wu, Q., Zhao, B., Dongye, S., Sun, L., An, B., & Xu, Q. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1566047 · Cited by 11
Han, Y., Zhu, X. B., Ye, Y., Deng, K. Y., Zhang, X. Y., & Song, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106608 · Cited by 9
Potential Glioprotective Strategies Against Diabetes-Induced Brain Toxicity
Sovrani, V., Bobermin, L. D., Schmitz, I., Leipnitz, G., & Quincozes‐Santos, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00393-3 · Cited by 11
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.